AstraZeneca was among the few gainers on Monday as the FTSE 100 had its sharpest fall in three weeks.
The shares inched higher by 0.8 per cent to £26.50 on the back of a Citigroup upgrade to “buy”.
By Bryce Elder and Neil Hume
Published: June 15 2009 08:31 | Last updated: June 15 2009 20:49
AstraZeneca was among the few gainers on Monday as the FTSE 100 had its sharpest fall in three weeks.
The shares inched higher by 0.8 per cent to £26.50 on the back of a Citigroup upgrade to “buy”.